Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Catherine Burzik, Bill Ward

Premium

Becton, Dickinson has appointed Catherine Burzik to its board of directors. She was formerly the president of Applied Biosystems, before it was acquired by Life Technologies, and most recently was president, CEO, and director of Kinetic Concepts. Currently, she is chair of the board of directors of VitaPath Genetics, chair of the Canisius College board of trustees, a member of the board of directors of Canisius, and on the board of trustees of the Keck Graduate School of Applied Life Sciences. She holds a BS in mathematics from Canisius College and an MS in mathematics from the University of Buffalo.


ZS Genetics, a North Reading, Mass.-based next-generation sequencing startup, has appointed Bill Ward to president and chief operating officer. Ward was founder, president, and CEO of ALIS before Carl Zeiss acquired it. He was also founder of Micrion and Beam Technologies.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.